Advanced Biomed Inc.
ADVB
$0.42
$0.001.16%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 44.85% | 49.30% | -52.43% | -241.83% | 67.19% |
| Total Depreciation and Amortization | -25.47% | -17.54% | -21.19% | -3.03% | -33.59% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | -- | -- | -- | -- |
| Change in Net Operating Assets | 70.06% | 56.90% | -6,275.15% | -124.68% | -25.56% |
| Cash from Operations | 60.47% | 54.72% | -305.04% | -2,734.34% | 93.76% |
| Capital Expenditure | 91.04% | -813.64% | -120.56% | 153.50% | 62.48% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 91.04% | -813.64% | -120.56% | 153.50% | 62.48% |
| Total Debt Issued | 153.85% | -31.29% | -38.13% | 3.86% | 0.10% |
| Total Debt Repaid | 98.66% | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -199.40% | 33,647.62% | 0.00% | 80.33% |
| Cash from Financing | 158.46% | -112.98% | 1,344.77% | 4.03% | 21.33% |
| Foreign Exchange rate Adjustments | -267.41% | 24.43% | -90.83% | 242.56% | -302.80% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 89.15% | -190.24% | 24,673.53% | -73.85% | 170.02% |